-
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
16 Jun 2025 11:00 GMT
… Drug Administration (FDA)-approved oral medicine indicated for the treatment … Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a … ) patients receiving levodopa-based therapy, hypomobility … ZURZUVAE and other antidepressant medicines may increase the …
-
Roche To Advance Prasinezumab Into Phase III Development For Early-Stage Parkinson's Disease
16 Jun 2025 06:13 GMT
… the two phase II trials and their open- … across the overall and levodopa-treated populations. Prasinezumab continues … medicine, of which more than 750 remain in open label treatment … majority shareholder in Chugai Pharmaceutical, Japan. For more information …
-
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease
16 Jun 2025 05:17 GMT
… across the overall and levodopa-treated populations.
Prasinezumab continues … medicine, of which more than 750 remain in open label treatment … is a clinical-stage biotechnology company with expertise in … ongoing and future clinical trials of prasinezumab; and …
-
Parkinson's Disease Market Research Analysis and Forecast, 2025-2035, Featuring Key Players - AbbVie, Merck & Co., GlaxoSmithKline, Novartis, and Teva Pharmaceutical - ResearchAndMarkets.com
13 Jun 2025 14:42 GMT
… stem cell-based treatments, and biologic drugs, the competition … pharmaceutical and biotechnology companies vying to develop and commercialize effective treatments … disease. While levodopa and other medications can alleviate …
1.5 Clinical Trial Analysis
1.6 …
-
Manganese-Induced Parkinsonism: A Review of Etiologies and Treatments
05 Jun 2025 21:28 GMT
… followed by symptomatic treatments with dopamine agonists, carbidopa-levodopa, monoamine oxidase B … related to their self-prepared drug use. The patient’s bradykinesia … Complementary medicine has been explored to improve the outcome of traditional treatments …
-
Small but 'life-changing' policy helps Parkinson's patients who need emergency care at Guelph's hospital
05 Jun 2025 12:02 GMT
… the more common medications for Parkinson's is Levodopa, used to … like you bringing your own pills'
Parkinson's … a pill, he's familiar with how demanding the medication schedule … restrictions.
"My little Parkinson pill isn't high on …
-
Parkinson’s treatment ‘bottleneck’ sees patients look elsewhere for care
04 Jun 2025 10:40 GMT
… over time and, unlike medication, can offer long-lasting … stimulation is also taking levodopa, the drug for Parkinson’s … of Parkinson’s treatment. Stem cell trials underway in Japan, … exercise-based rehabilitation.
Many doctors highlighted the importance of …
-
INBRIJA Positioned for Stronger Market Penetration as Demand Grows for Inhaled Parkinson's Therapy| DelveInsight
29 May 2025 23:13 GMT
… antagonists. These medications primarily aim to … compared to traditional levodopa treatments, which could … .4
Clinical Trials Information
2.5 … Pharmaceuticals, Acadia Pharmaceuticals Inc., Otsuka America Pharmaceutical, Lundbeck LLC, Jazz Pharmaceuticals …
-
Jay Glazer and Wife Rosie Glazer Offer Candid Look at ADHD and Relationships in New Qelbree® Content Series with Supernus Pharmaceuticals
29 May 2025 12:30 GMT
… to a doctor about all the medications they take, … of prescription drugs to the FDA. Visit www.fda.gov… . About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a biopharmaceutical … treatments for ADHD, dyskinesia in PD patients receiving levodopa- …
-
Mitsubishi Tanabe Pharma America Announces U.S. FDA Acceptance of New Drug Application Resubmission for Investigational ND0612 for the Treatment of Motor Fluctuations in Parkinson's Disease
28 May 2025 18:50 GMT
… levodopa/carbidopa (LD/CD), for the treatment … double-dummy (DBDD) BouNDless trial ( NCT04006210 ), which … and focusing on ethical pharmaceuticals. MTPC is headquartered … precision medicine" to provide drugs with high treatment satisfaction …